Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease

Journal of Immunology Research
Géraldine GeldersAnke Van der Perren

Abstract

Neurodegenerative diseases such as Parkinson's disease (PD) and Alzheimer's disease (AD) impose a pressing burden on our developed and consequently aging society. Misfolded protein aggregates are a critical aspect of several neurodegenerative diseases. Nevertheless, several questions remain unanswered regarding the role of misfolded protein aggregates and the cause of neuronal cell death. Recently, it has been postulated that neuroinflammatory processes might play a crucial role in the pathogenesis of PD. Numerous postmortem, brain imaging, epidemiological, and animal studies have documented the involvement of the innate and adaptive immunity in neurodegeneration. Whether these inflammatory processes are directly involved in the etiology of PD or represent secondary consequences of nigrostriatal pathway injury is the subject of intensive research. Immune alterations in response to extracellular α-synuclein may play a critical role in modulating Parkinson's disease progression. In this review, we address the current concept of neuroinflammation and its involvement in PD-associated neurodegeneration.

References

Jun 12, 1989·Brain Research·H Akiyama, P L McGeer
Jan 1, 1988·Acta Neuropathologica·P L McGeerE G McGeer
Jan 1, 1993·Neuroscience·P DamierF Javoy-Agid
Aug 28, 1997·Nature·M G SpillantiniM Goedert
Jan 4, 2001·Journal of Neuroimmunology·J BasE Buendia
Dec 25, 2002·Neurobiology of Aging·Heiko BraakEva Braak
Oct 3, 2003·British Medical Bulletin·Adriano AguzziMarkus Glatzel
Jun 16, 2004·Proceedings of the National Academy of Sciences of the United States of America·Eric J BennerHoward E Gendelman
Sep 1, 2004·Cell and Tissue Research·Heiko BraakKelly Del Tredici
Sep 27, 2005·Neurobiology of Disease·Alexander GerhardDavid J Brooks
Oct 13, 2005·Brain : a Journal of Neurology·Carolyn F OrrGlenda M Halliday
Oct 22, 2005·Annals of Neurology·Honglei ChenAlberto Ascherio
Mar 22, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Thanh G TonHarvey Checkoway
Apr 12, 2006·Neurology·Miguel A HernánLuis A García Rodríguez
Apr 14, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·George K TofarisMaria Grazia Spillantini
Oct 7, 2006·Journal of Leukocyte Biology·Roberta BianchiRosario Donato
Dec 21, 2006·Nature Reviews. Neuroscience·Michelle L BlockJau-Shyong Hong
Apr 24, 2007·Journal of Neurochemistry·Katerina K PapachroniVladimir L Buchman
Jun 1, 2007·Neurobiology of Aging·Xiaomin SuHoward J Federoff
Aug 7, 2007·Journal of Leukocyte Biology·Ashley D ReynoldsR Lee Mosley
May 22, 2008·Biochemical and Biophysical Research Communications·He-Jin LeeSeung-Jae Lee
Jul 17, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Melissa K McCoyMalú G Tansey
Dec 24, 2008·The Journal of Clinical Investigation·Vanessa BrochardStéphane Hunot
Mar 20, 2009·Human Molecular Genetics·Suzanne Lesage, Alexis Brice
Jun 25, 2009·Neurotoxicity Research·Mika ShimojiItalo Mocchetti
Aug 15, 2009·Journal of Neuropathology and Experimental Neurology·Shinji HigashiEizo Iseki
Oct 23, 2009·Parkinsonism & Related Disorders·Christopher H HawkesHeiko Braak

❮ Previous
Next ❯

Citations

Oct 26, 2018·CPT: Pharmacometrics & Systems Pharmacology·Suruchi BakshiPiet H van der Graaf
Oct 1, 2018·The European Journal of Neuroscience·Noémie CrestoEmmanuel Brouillet
Aug 7, 2019·Journal of Cellular and Molecular Medicine·Shuqin ZhanQiang Ding
Nov 9, 2019·Behavioural Pharmacology·Lais S RodriguesMarcelo M S Lima
Sep 27, 2019·Clinical and Experimental Pharmacology & Physiology·Yik L ChanHui Chen
Jan 16, 2020·Antioxidants·Federica De LazzariMarco Bisaglia
Feb 14, 2020·Proceedings of the National Academy of Sciences of the United States of America·Tanusree SenNilkantha Sen
Aug 20, 2019·Molecular Neurodegeneration·Sonia GeorgePatrik Brundin
May 21, 2020·Journal of Receptor and Signal Transduction Research·Fu Sun, Fengguo Liu
Feb 24, 2019·Reviews in the Neurosciences·Ava NasrolahiJavad Mahmoudi
Feb 6, 2020·Experimental and Therapeutic Medicine·Hailong SongZezong Gu
Sep 4, 2020·Experimental Biology and Medicine·Santosh R D'Mello, Mark C Kindy
Mar 10, 2020·Evidence-based Complementary and Alternative Medicine : ECAM·Nur Shafika Mohd Sairazi, K N S Sirajudeen
Jun 9, 2020·Frontiers in Neuroscience·Rebecca L WallingsMalú Gámez Tansey
Aug 18, 2020·Molecular Neurobiology·Thura Tun OoSiriporn C Chattipakorn
Apr 4, 2019·Frontiers in Pharmacology·Hayate JavedShreesh Kumar Ojha
Mar 27, 2020·Frontiers in Aging Neuroscience·Qing YeXiqun Chen
May 22, 2020·Molecular Neurobiology·Kevin M BudgeFayez F Safadi
Oct 2, 2020·Cells·Tuuli-Maria SonninenŠárka Lehtonen
Oct 6, 2020·Frontiers in Pharmacology·Boju SunTonghua Liu
Jul 14, 2020·Evidence-based Complementary and Alternative Medicine : ECAM·Lili TangYang Zhao
Oct 31, 2018·Frontiers in Neuroscience·Driton Vela
Jan 27, 2019·International Journal of Molecular Sciences·Eugene BokHyung-Jun Kim
Sep 12, 2019·Frontiers in Pharmacology·Brigitta DukayMelinda E Tóth
Sep 29, 2019·Journal of Caffeine and Adenosine Research·Sergi Ferré, Francisco Ciruela
Apr 26, 2020·Nature Reviews. Neurology·Eng-King TanJoseph Jankovic

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
enzyme-linked immunosorbent assay

Related Concepts

Related Feeds

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Epidemiology of Aging

This feed focuses on epidemiology of aging and aging-related conditions, including Alzheimer’s disease, dementia, and age-associated cognitive impairment. Here is the latest research.